<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="translate">
            <roleset id="translate.01" name="molecular event of producing genetic product called protein&#x0A;" wordnet="10">
                <roles>
                    <role n="0" descr="resultant product &#x09;&#x09;&#x09;// protein //&#x0A;" />
                    <role n="1" descr="source &#x09;&#x09;&#x09;&#x09;&#x09;// mRNA, transcript // &#x0A;" />
                    <role n="2" descr="location as tissue, cell, vitro&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A transcript can be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A transcript has been efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A transcript has been shown to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A transcript is able to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A transcript is efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A transcript is likely to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A transcript is observed to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>A transcript may be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>A transcript may have been efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>A transcript was efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>A transcript will be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>A transcript, as our data has shown, can be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>A transcript, as our data has shown, can be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>A transcript, as our data has shown, has been efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>A transcript, as our data has shown, has been shown to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>A transcript, as our data has shown, has been shown to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>A transcript, as our data has shown, has been translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>A transcript, as our data has shown, is able to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>A transcript, as our data has shown, is able to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>A transcript, as our data has shown, is efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>A transcript, as our data has shown, is likely to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>A transcript, as our data has shown, is likely to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>A transcript, as our data has shown, is observed to be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>A transcript, as our data has shown, is observed to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>A transcript, as our data has shown, is translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>A transcript, as our data has shown, may be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>A transcript, as our data has shown, may be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>A transcript, as our data has shown, may have been efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>A transcript, as our data has shown, may have been translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>A transcript, as our data has shown, was efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>A transcript, as our data has shown, was translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>A transcript, as our data has shown, will be efficiently translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>A transcript, as our data has shown, will be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">A transcript, as our data has shown,</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>Alternative splicing of exon 4 results in a transcript being able to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Alternative splicing of exon 4 results in a transcript having been translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>Alternative splicing of exon 4 results in a transcript likely to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>Alternative splicing of exon 4 results in a transcript observed to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>Alternative splicing of exon 4 results in a transcript shown to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>Alternative splicing of exon 4 results in a transcript translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>Alternative splicing of exon 4 results in a transcript which can be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>Alternative splicing of exon 4 results in a transcript which has been shown to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Alternative splicing of exon 4 results in a transcript which has been translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>Alternative splicing of exon 4 results in a transcript which is able to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>Alternative splicing of exon 4 results in a transcript which is likely to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>Alternative splicing of exon 4 results in a transcript which is observed to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>Alternative splicing of exon 4 results in a transcript which is translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>Alternative splicing of exon 4 results in a transcript which may be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>Alternative splicing of exon 4 results in a transcript which may have been translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>Alternative splicing of exon 4 results in a transcript which was translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>Alternative splicing of exon 4 results in a transcript which will be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">a transcript</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>ISGF3 gamma being able to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>ISGF3 gamma being able to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>ISGF3 gamma observed to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>ISGF3 gamma observed to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>ISGF3 gamma properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>ISGF3 gamma shown to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>ISGF3 gamma shown to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>ISGF3 gamma that can be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>ISGF3 gamma that can be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>ISGF3 gamma that has been properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>ISGF3 gamma that has been shown to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>ISGF3 gamma that has been shown to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>ISGF3 gamma that has been translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>ISGF3 gamma that is able to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>ISGF3 gamma that is able to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>ISGF3 gamma that is likely to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>ISGF3 gamma that is likely to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>ISGF3 gamma that is observed to be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>ISGF3 gamma that is observed to be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>ISGF3 gamma that is properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>ISGF3 gamma that is translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>ISGF3 gamma that may be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>ISGF3 gamma that may be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>ISGF3 gamma that may have been properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>ISGF3 gamma that may have been translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>ISGF3 gamma that was properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>ISGF3 gamma that was translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>ISGF3 gamma that will be properly translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>ISGF3 gamma that will be translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>ISGF3 gamma translated in vitro from recombinant clones bound DNA with a specificity indistinguishable from that of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been shown to be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been shown to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators may be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators may be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators may have been completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators may have been translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators were completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators were translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be completely translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>More than 100 proteins and polypeptides which are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>Stat1 Y701F which can be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>Stat1 Y701F which can be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>Stat1 Y701F which has been probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>Stat1 Y701F which has been shown to be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>Stat1 Y701F which has been shown to be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>Stat1 Y701F which has been translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>Stat1 Y701F which is able to be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>Stat1 Y701F which is able to be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>Stat1 Y701F which is likely to be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>Stat1 Y701F which is likely to be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>Stat1 Y701F which is observed to be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>Stat1 Y701F which is observed to be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>Stat1 Y701F which is probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>Stat1 Y701F which is translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>Stat1 Y701F which may be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>Stat1 Y701F which may be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>Stat1 Y701F which was probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>Stat1 Y701F which was translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>Stat1 Y701F which will be probably translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="123">
                    <text>Stat1 Y701F which will be translated in vitro can also dimerize on the LMP2 GAS.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="124">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are able to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="125">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are likely to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="126">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are observed to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="127">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="128">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 can be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="129">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 have been shown to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="130">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 have been translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="131">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 have the ability to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="132">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 may be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="133">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 may have been translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="134">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are able to be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="135">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are able to be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="136">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are likely to be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="137">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are likely to be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="138">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are observed to be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="139">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are observed to be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="140">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="141">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that are translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="142">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that can be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="143">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that can be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="144">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have been properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="145">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have been shown to be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="146">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have been shown to be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="147">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have been translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="148">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have the ability to be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="149">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have the ability to be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="150">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="151">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="152">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may have been properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="153">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may have been translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="154">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that will be properly translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="155">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that will be translated in vitro are partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="156">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 will be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="157">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, are able to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="158">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, are likely to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="159">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, are observed to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="160">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, are translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="161">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, can be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="162">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, have been shown to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="163">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, have been translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="164">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, have the ability to be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="165">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, may be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="166">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, may have been translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="167">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data reveals, will be translated in vitro and partially purified on heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="168">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being able to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="169">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being likely to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="170">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides having been translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="171">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides observed to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="172">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides shown to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="173">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are able to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="174">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are likely to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="175">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are observed to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="176">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="177">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="178">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been shown to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="179">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="180">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have the ability to be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="181">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that may be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="182">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that may have been translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="183">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that were translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="184">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="185">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides translated from open reading frames.</text>
                    <arg n="0">more than 100 proteins and polypeptides</arg>
                    <arg n="0">open reading frames</arg>
                </example>
                <example src="EGRAM" no="186">
                    <text>This mutant can be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="187">
                    <text>This mutant can be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="188">
                    <text>This mutant has been efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="189">
                    <text>This mutant has been shown to be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="190">
                    <text>This mutant has been shown to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="191">
                    <text>This mutant has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="192">
                    <text>This mutant is able to be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="193">
                    <text>This mutant is able to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="194">
                    <text>This mutant is efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="195">
                    <text>This mutant is likely to be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="196">
                    <text>This mutant is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="197">
                    <text>This mutant is observed to be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="198">
                    <text>This mutant is observed to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="199">
                    <text>This mutant is translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="200">
                    <text>This mutant may be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="201">
                    <text>This mutant may be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="202">
                    <text>This mutant may have been efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="203">
                    <text>This mutant may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="204">
                    <text>This mutant will be efficiently translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="205">
                    <text>This mutant will be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="206">
                    <text>This mutant, as our study reveals, can be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="207">
                    <text>This mutant, as our study reveals, has been shown to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="208">
                    <text>This mutant, as our study reveals, has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="209">
                    <text>This mutant, as our study reveals, is able to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="210">
                    <text>This mutant, as our study reveals, is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="211">
                    <text>This mutant, as our study reveals, is observed to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="212">
                    <text>This mutant, as our study reveals, is translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="213">
                    <text>This mutant, as our study reveals, may be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="214">
                    <text>This mutant, as our study reveals, may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="215">
                    <text>This mutant, as our study reveals, will be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="216">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which can be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="217">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which can be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="218">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been shown to be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="219">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been shown to be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="220">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="221">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="222">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is able to be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="223">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is able to be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="224">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is likely to be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="225">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is likely to be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="226">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="227">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="228">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="229">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="230">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which may be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="231">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which may be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="232">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which may have been successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="233">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which may have been translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="234">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which was successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="235">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which was translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="236">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which will be successfully translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
                <example src="EGRAM" no="237">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which will be translated in reticulocyte lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte lysates</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
